|Day Low/High||56.83 / 58.26|
|52 Wk Low/High||44.81 / 68.00|
Jim Cramer doesn't buy the backlash against Amazon. He says Prime is a very powerful tool and an irresistible bargain.
Jim Cramer is bullish on Citigroup, Zoetis, Idexx Labs, AbbVie, Nucor, and Alexion.
We continue to believe in the story of these 3 companies, despite current weakness.
Jim Cramer focuses in on AK Steel Holdings, Cara Therapeutics, Nucor, and Smart and Final Stores.
The real exaggeration, says Jim Cramer, may be the influence of the bond market. But you can't ignore bonds, either.
Longbow upgraded several steel stocks on Monday, citing strong evidence of an improved steel distribution market.
Olin said his industry contacts see a $50 to $60 per ton jump in steel prices by year end, making for a $630 to $640 per ton price.
A look some of our holdings and what is driving their trading this morning.
Steel stocks like AK Steel, U.S. Steel, Steel Dynamics and Nucor have a lot more upside. At least, according to one analyst.
Jim Cramer discusses bonds and also talks about why panicking off the Fed is a superbad idea.
Tech rotation, oil and Fed rate hike keep markets on even (make that flat) keel. Several portfolio positions get beefed up.
Our takeaways and how we are thinking about the impact.
You may want to stay away from tech, from the crowded trades. But maybe you shouldn't give up so easily, says Jim Cramer.
There's a very good reason why so many clamor for these stocks.
Other steel shares followed Nucor down, including AK Steel and U.S. Steel.
Today's opportunity is too attractive to pass up, so we continue to bolster our position.
After a busy Thursday, markets look forward to economic data and the Fed meeting next week. In the portfolio, we dropped a tech stock and added a healthcare name.
Trump administration may be close to ramping anti-dumping initiates.